New drug could extend the lives of breast cancer patients
LMU researchers have successfully tested a new drug which can significantly extend the lives of breast cancer patients. Patients with ...
Tag: Trastuzumab
Antibody-drug conjugate shows preclinical efficacy
A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, "Entering the golden age for ...
Simple technique boosts antibody delivery for treating brain diseases
The blood-brain barrier blocks the entry of antibodies into the brain. This limits the potential use of antibody therapeutics to ...
Immune system B-cells may be better in predicting HER2-positive breast cancer treatment response
Researchers at UNC Lineberger Comprehensive Cancer Center and colleagues have found that measuring activation of immune-system B cells may be ...
T-DXd shows high efficacy in HER2-positive breast cancer patients previously treated with T-DM1
Compared with capecitabine-based regimens, trastuzumab deruxtecan (T-DXd) led to higher response rates and longer survival in the third-line setting for ...
